Skip to main content
. 2023 Mar 17;13(3):e069857. doi: 10.1136/bmjopen-2022-069857

Table 1.

Participant characteristics (n=27)

Characteristic n
Age, years 47.3 (8.7)
Sex
 Male 22 (81.5)
 Female 5 (18.5)
Ethnicity
 White British 14 (51.9)
 Black British 4 (14.8)
 Other 9 (33.3)
OAT
 Methadone 17 (63.0)
 Buprenorphine 10 (37.0)
OAT episode and regimen
 Existing episode—change to self-administered dosing 20 (74.1)
 Existing episode—already self-administered dosing 2 (7.1)
 New episode—self-administered dosing from induction 5 (18.5)

Numbers in parentheses are SD or percentage.

OAT, opioid agonist treatment.